Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Autopsy shows Williams had DLB

The recent death of the beloved comedian and actor Robin Williams by suicide took fans by complete surprise and left many in mourning for the master of improvisation. A recent report in Salon provides details from Williams' autopsy report that indicates the presence of dementia with Lewy bodies (DLB), which may explain some of his uncharacteristic behavior of late. In addition to DLB, Williams also suffered from Parkinson's.

Thumbnail

Novel imaging agent targets pancreatic cancer

MabVax Therapeutic Holdings, in collaboration with the Memorial Sloan Kettering Cancer Center (MSKCC), is presenting an investigational agent for imaging pancreatic cancer and aiding pancreatic tumor resection, MabVax announced Nov. 19.

Thumbnail

The age of theranostic nanoparticles

Over the past several years, theranostic nanoparticle studies have provided several shining examples of where molecular cancer imaging is going. In this review published ahead of print Nov. 20 in the Journal of Nuclear Medicine, researchers discuss the triumphs and tribulations of these tiny yet potent structures.

Thumbnail

Year in Images 2014

This year, Molecular Imaging Insight is not only providing some of the most stunning images from our pages, but also a few research exclusives and offerings from a handful of scientific meetings from around the world, including the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the World Molecular Imaging Congress (WMIC) and the European Congress of Radiology (ECR).

Thumbnail

The Evolution of SPECT

The evolution of SPECT imaging has taken many twists and turns as both equipment technology and new radiopharmaceuticals have been developed over the past decade.

Thumbnail

The Business of Molecular Imaging: A Panoply of Challenges

As is true in all clinical disciplines, nuclear medicine practitioners face challenges and obstacles that do not end with procedures and patient care.

Thumbnail

Lightspeed: The Coming of Age of Proton Therapy

Proton therapy used to be the next-generation cancer treatment that was larger than life and too expensive for any institution other than the most cutting-edge research hospital.

Thumbnail

WMIC Looking Ahead to 2015

The 2014 World Molecular Imaging Congress (WMIC) put a spotlight on the basic science and translation of molecular imaging at the World Trade Center in Seoul, South Korea, in September.